Clinical trial

XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT06568562

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-12-09

PhasePHASE2

Study timeline

Study start (actual)2024-12-09Date precision: day

Registry last updated2026-06-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Castration-resistant Prostate Cancerunresolved

Interventions

XL092DRUG

Sponsors & collaborators

University of Utahlead sponsor

Exelixiscollaborator

Mapped research locations

Salt Lake CityUtah, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06568562 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.